Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker TNYA
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 4, 2026 | TNYA Tenaya Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 5, 2026 | TNYA Tenaya Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 2, 2026 | TNYA Tenaya Therapeutics, Inc. | 1.02 Termination of a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 29, 2026 | TNYA Tenaya Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 29, 2026 | TNYA Tenaya Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 29, 2026 | TNYA Tenaya Therapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 29, 2026 | TNYA Tenaya Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 6, 2026 | TNYA Tenaya Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 11, 2026 | TNYA Tenaya Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 5, 2026 | TNYA Tenaya Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jan 30, 2026 | TNYA Tenaya Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jan 30, 2026 | TNYA Tenaya Therapeutics, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Jan 2, 2026 | TNYA Tenaya Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Dec 12, 2025 | TNYA Tenaya Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 12, 2025 | TNYA Tenaya Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Dec 11, 2025 | TNYA Tenaya Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 11, 2025 | TNYA Tenaya Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 10, 2025 | TNYA Tenaya Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 7, 2025 | TNYA Tenaya Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 6, 2025 | TNYA Tenaya Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 30, 2025 | TNYA Tenaya Therapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 7, 2025 | TNYA Tenaya Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 18, 2025 | TNYA Tenaya Therapeutics, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Mar 28, 2025 | TNYA Tenaya Therapeutics, Inc. | 2.05 Costs Associated with Exit or Disposal Activities | 8-K | 8-K ↗ |
| Mar 10, 2025 | TNYA Tenaya Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 4, 2025 | TNYA Tenaya Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 4, 2025 | TNYA Tenaya Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 4, 2025 | TNYA Tenaya Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Feb 7, 2025 | TNYA Tenaya Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jan 28, 2025 | TNYA Tenaya Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Dec 17, 2024 | TNYA Tenaya Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 17, 2024 | TNYA Tenaya Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 17, 2024 | TNYA Tenaya Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 6, 2024 | TNYA Tenaya Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
34 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:51 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances